Spontaneous reporting of adverse drug reactions in Cuba: Integrating continuous education, training and research in a network approach [3]

British Journal of Clinical Pharmacology

Volumn 54, Issue 3, 2002, Pages 335-336

  Debesa, Frank ^a   Jiménez, Giset ^a   Figueras, Albert ^b   Diogène, Eduard ^b   Pérez Peña, Julián ^a   Avila, Jenny ^a   Laporte, Joan Ramon ^b  

^a Centro para el Desarrollo de la Farmacoepidemiologia   (Cuba)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; INDOMETACIN; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G;

DRUG MONITORING; DRUG SAFETY; DRUG UTILIZATION; HEADACHE; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; PRURITUS; RASH; SIDE EFFECT; VOMITING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CUBA; EDUCATION, MEDICAL, CONTINUING; HUMANS;

EID: 0036379541     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2002.01635.x     Document Type: Letter

References (4)

1. Belton KJ. The European Pharmacovigilance Research Group. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997; 52: 423-427.
2. Laporte JR, Dotres C, Diogène E, Pérez Peña J, Reggi V, Márquez M. Cuba: improving the use of medicines. Lancet 1997; 349: S114.
3. Lindquist M, Edwards IR. Adverse drug reaction reporting in Europe. some problems of comparison. Int J Risk Saf Med 1993; 4: 35-46.
4. Figueras A, Pedrós C, Valsecia M, Laporte JR. Therapeutic ineffectiveness: Heads or tails? Drug Safety 2002; 25: 485-487.